Global Esoteric Testing Market, By Type (Infectious Diseases, Endocrinology test, Oncology test, Toxicology Testing, Neurology Testing and others), By Technology (Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay, Flow Cytometry and others), By Laboratory Type, By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) and Forecast to 2025.
Global Esoteric Testing Market is expected to reach USD 42.68 Billion by 2025, from USD 18.25 Billion in 2017 growing at a CAGR of 11.2% during the forecast period of 2018 to 2025.
Request For Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-esoteric-testing-market
Top Key Competitors:
- Quest Diagnostics
- Opko Health
- Miraca Holdings
- Myriad Genetics
- Sonic Healthcare
- Primary Health Care
- Foundation Medicine
- ACM Global Laboratories
- Arup Laboratories
- Fulgent Genetics
- Mayo Medical Laboratories
- Spectra Laboratories
- Among Others.
This report consists of below pages:
- No of pages: 350
- No of Figures: 60
- No of Tables: 220
Get 25% Discount Instant Mail us @ [email protected]
Esoteric testing is the analysis of unique or rare molecules whose assays are not performed in the routine clinical lab. Esoteric testing requires sophisticated equipment and materials as well as experienced personnel to perform the test. The equipment and devices are generally outsourced to special clinical labs as it is very cost effective for hospitals. The tests are ordered very less frequently and the price of these test are highly expensive. Esoteric testing generally includes genetics, immunology, microbiology, toxicology, oncology, and molecular diagnostics test. The main challenge in estoric testing is that they require highly experienced and qualified medical technologist apart from that expensive materials. In August 2015, NYU Langone Health and Sonic Healthcare USA came into a joint venture to form a laboratory. This agreement enhanced the outpatient laboratory services to over 2,000 physicians affiliated with the NYU hospital system. In June 2017, Quest Diagnostics announced the complete acquisition of Medfusion and ClearPoint and form National Precision Oncology Center. This acquisition provide better facilities for cancer patients precise diagnostics like genomic sequencing of cancerous DNA which in turn help physician select therapy, clinical trial and monitor response. The main reason of this acquisition was to develop a regional and a national reference and esoteric testing business serving hospitals, in Dallas.
Drivers and Restraints:
- Increase in prevalence of chronic disease.
- Increase in geriatric population.
- Number of patients suffering from infectious disease increased.
- Increased awareness of personalized medicine
- Development of specific markers used in genomic and proteomics
- Advancement in technology of esoteric testing
- Reimbursement Scenario
- Less patient’s awareness.
For Any Query Speak to Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-esoteric-testing-market
Based on type:
- Infectious Diseases Testing
- Endocrinology Testing
- Oncology Testing
- Genetic Testing
- Toxicology Testing Immunology Testing
- Neurology Testing
Based on technology:
- Chemiluminescence Immunoassay
- Enzyme-Linked Immunosorbent Assay
- Flow Cytometry Real-Time PCR
- Mass Spectrometry
- Others Technologies
Based on the laboratory type:
- Independent & Reference Laboratories
- Hospital Laboratories.
Based on geography:
- North America
- South America
- Middle East & Africa
Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others
The global esoteric testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. The report includes market shares of esoteric testing market for global, Europe, North America, Asia Pacific and South America.